Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Kamada Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$5.5

2024-10-29

Market Capitalization

$317 M

2024-10-29

Revenue

$180.5 M

FY, 2025

CreditSafe Score

?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue114.5M127.2M133.2M103.6M129.3M142.5M161.0M180.5M
Cost of goods sold70.0M57.4M65.4M52.8M59.1M61.7M63.9M72.1M
Gross profit44.5M69.8M67.9M50.9M70.2M80.8M97.2M108.4M
Gross profit margin, %54.9%51.0%49.1%54.3%56.7%60.4%60.1%
Operating expense total21.5M42.5M44.8M47.0M54.6M58.0M63.2M67.2M
Depreciation and amortization3.7M4.5M3.9M4.5M11.1M12.7M13.9M14.9M
EBITDA23.0M27.3M23.1M3.8M15.7M22.8M34.0M41.2M
EBITDA margin, %21.5%17.4%3.7%12.1%16.0%21.1%22.8%
EBIT19.3M22.8M19.2M(696.0K)4.5M10.1M20.1M26.2M
EBIT margin, %17.9%14.4%-0.7%3.5%7.1%12.5%14.5%
Interest income820.0K1.1M1.0M295.0K91.0K588.0K2.1M1.9M
Interest expense340.0K293.0K266.0K1.3M914.0K1.3M660.0K864.0K
Pre tax profit20.3M23.0M18.6M(1.9M)(2.3M)8.4M13.3M23.5M
Income tax expense(2.0M)730.0K1.4M345.0K62.0K145.0K(1.1M)3.3M
Net Income22.3M22.3M17.1M(2.2M)(2.3M)8.3M14.5M20.2M

Footer menu